Avidity Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Avidity Biosciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About RNA
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases.
CEOSarah Boyce
CEOSarah Boyce
Employees391
Employees391
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees391
Employees391
RNA Key Statistics
Market cap10.18B
Market cap10.18B
Price-Earnings ratio-19.62
Price-Earnings ratio-19.62
Dividend yield—
Dividend yield—
Average volume15.74M
Average volume15.74M
High today$69.88
High today$69.88
Low today$69.59
Low today$69.59
Open price$69.79
Open price$69.79
Volume6.03M
Volume6.03M
52 Week high$70.51
52 Week high$70.51
52 Week low$21.51
52 Week low$21.51
Analyst ratings
67%
of 15 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
People also own
Based on the portfolios of people who own RNA. This list is generated using Robinhood data, and it’s not a recommendation.